Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00809679 · ClinicalTrials.gov registry record · Phase 2
Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia
A Phase 2 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT00809679: Clinical Trial Phase 2 study, sponsored by Pfizer.
NCT00809679 is a Phase 2 study that was terminated before completion, run by Pfizer. The registered enrollment target is 19 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00809679, a Phase 2 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of T-62 in subjects with postherpetic neuralgia.
Interventions
- OTHER Placebo
- DRUG T-62 Dose 1
- DRUG T-62 Dose 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Why NCT00809679 stopped before completion
NCT00809679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00809679 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00809679 about?
NCT00809679 is a clinical study titled "Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia". The purpose of this study is to evaluate the safety and efficacy of T-62 in subjects with postherpetic neuralgia.
What is the current status of trial NCT00809679?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2008-12. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00809679?
The interventions under investigation include: Placebo (OTHER), T-62 Dose 1 (DRUG), T-62 Dose 2 (DRUG).
Who is sponsoring clinical trial NCT00809679?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00809679's enrollment target sits among peer trials
19 1894th of 2000 higher than 103 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia